In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens.
Quindós
G
G
Departamento de Inmunología, Microbiología y Parasitología, Facultad de Medicina y Odontología, Universidad del País Vasco, Vizcaya, Spain. oipquang@lg.ehu.es
Carrillo-Muñoz
A J
AJ
Ruesga
M T
MT
Alonso-Vargas
R
R
Miranda
Y
Y
Tur-Tur
C
C
Rubio
M
M
Wallace
T L
TL
Cossum
P A
PA
Martín-Mazuelos
E
E
Cisterna
R
R
Pontón
J
J
D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008081:Liposomes; D008826:Microbial Sensitivity Tests / Q000379:methods / Q000592:standards; D003904:Mitosporic Fungi / Q000187:drug effects*; D009181:Mycoses / Q000382:microbiology; D009761:Nystatin / Q000008:administration & dosage / Q000494:pharmacology*; D009894:Opportunistic Infections / Q000382:microbiology
D000935:Antifungal Agents; D008081:Liposomes; D009761:Nystatin